Validation of immune status using ESTIMATE revealed that ImmuneScore, StromalScore, and ESTIMATEScore were significantly lower in “low PD-L1 expression” NSCLC samples relative to controls (Figure 2B). The gene discussed is CD274; the disease is non-small cell lung carcinoma.